Atrasentan
- Generic Name
- Atrasentan
- Drug Type
- Small Molecule
- Chemical Formula
- C29H38N2O6
- CAS Number
- 173937-91-2
- Unique Ingredient Identifier
- V6D7VK2215
Overview
Atrasentan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. It is a novel, selective endothelin A receptor antagonist (SERA).
Background
Atrasentan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. It is a novel, selective endothelin A receptor antagonist (SERA).
Indication
Investigated for use/treatment in prostate cancer and cancer/tumors (unspecified).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath